Global BCG Vaccine Market Size study, by Type (Immune BCG and Therapy BCG) Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Application (Hospitals, Clinics, Others) and Regional Forecasts 2020-2027

BIZ4355421
200 Pages
May 2021
Pharmaceuticals

Download Sample Get Discount

Global BCG Vaccine Market is valued approximately at USD 23.25 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.53% over the forecast period 2020-2027. The Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine available to prevent tuberculosis (TB). In countries with a high prevalence of tuberculosis, one dosage is prescribed for babies close to the time of birth. However, in regions where tuberculosis is rare, only children at high risk are usually immunized, while confirmed cases of tuberculosis are directly screened and administered. The vaccine also immunizes people not diagnosed ith tuberculosis and are not vulnerable to drug-resistant tuberculosis. Rising prevalence of tuberculosis, especially in developing and underdeveloped countries, as well as technological advances in the field of vaccine science, are the major factors driving the growth of the BCG vaccine market. Also, as per the Global Tuberculosis Report of 2018, the majority of TB patients (66%) live in one of eight countries: India (27%), China (9%), Indonesia (8%), the Philippines (6%), Pakistan (5%), Nigeria (4%), Bangladesh (4%) or South Africa (3 percent). In addition, growing birth rates across the world, especially in China and India, are leading to substantial demand growth. Moreover, cohesive government policies and a global focus on immunization services are pushing the growth of the market upwards. Untapped investment markets in developing regions are projected to have several possibilities for market expansion.

However, side effects of BCG vaccines impede the growth of the market over the forecast period of 2020-2027.

The regional analysis of global BCG Vaccine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia pacific is the leading/significant region across the world in terms of market share owing to the high prevalence of TB in Asian countries such as India, Pakistan, Bangladesh and others. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly increasing government efforts in form of vaccination drives would create lucrative growth prospects for the BCG Vaccine market across Asia-Pacific region.

Major market player included in this report are:

Merck & Co. Inc.

Sanofi Pasteur

Japan BCG Laboratory

China National Biotech Group

Serum Institute of India Pvt. Ltd.

InterVax Ltd.

GreenSignal Bio Pharma Limited (GSBPL)

Statens Serum Institute

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Immune BCG

Therapy BCG

By Demographics:

Pediatrics (0-18 Years)

Adults (19-35 Years)

By Application:

Hospitals

Clinics

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global BCG Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)

1.2.1. BCG Vaccine Market, by Region, 2018-2027 (USD Million)

1.2.2. BCG Vaccine Market, by Type, 2018-2027 (USD Million)

1.2.3. BCG Vaccine Market, by Demographics, 2018-2027 (USD Million)

1.2.4. BCG Vaccine Market, by Application, 2018-2027 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global BCG Vaccine Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global BCG Vaccine Market Dynamics

3.1. BCG Vaccine Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global BCG Vaccine Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economic

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global BCG Vaccine Market, by Type

5.1. Market Snapshot

5.2. Global BCG Vaccine Market by Type, Performance - Potential Analysis

5.3. Global BCG Vaccine Market Estimates & Forecasts by Type 2017-2027 (USD Million)

5.4. BCG Vaccine Market, Sub Segment Analysis

5.4.1. Immune BCG

5.4.2. Therapy BCG

Chapter 6. Global BCG Vaccine Market, by Demographics

6.1. Market Snapshot

6.2. Global BCG Vaccine Market by Demographics, Performance - Potential Analysis

6.3. Global BCG Vaccine Market Estimates & Forecasts by Demographics 2017-2027 (USD Million)

6.4. BCG Vaccine Market, Sub Segment Analysis

6.4.1. Pediatrics (0-18 Years)

6.4.2. Adults (19-35 Years)

Chapter 7. Global BCG Vaccine Market, by Application

7.1. Market Snapshot

7.2. Global BCG Vaccine Market by Application, Performance - Potential Analysis

7.3. Global BCG Vaccine Market Estimates & Forecasts by Application 2017-2027 (USD Million)

7.4. BCG Vaccine Market, Sub Segment Analysis

7.4.1. Hospitals

7.4.2. Clinics

7.4.3. Others

Chapter 8. Global BCG Vaccine Market, Regional Analysis

8.1. BCG Vaccine Market, Regional Market Snapshot

8.2. North America BCG Vaccine Market

8.2.1. U.S. BCG Vaccine Market

8.2.1.1. Type breakdown estimates & forecasts, 2017-2027

8.2.1.2. Demographics breakdown estimates & forecasts, 2017-2027

8.2.1.3. Application breakdown estimates & forecasts, 2017-2027

8.2.2. Canada BCG Vaccine Market

8.3. Europe BCG Vaccine Market Snapshot

8.3.1. U.K. BCG Vaccine Market

8.3.2. Germany BCG Vaccine Market

8.3.3. France BCG Vaccine Market

8.3.4. Spain BCG Vaccine Market

8.3.5. Italy BCG Vaccine Market

8.3.6. Rest of Europe BCG Vaccine Market

8.4. Asia-Pacific BCG Vaccine Market Snapshot

8.4.1. China BCG Vaccine Market

8.4.2. India BCG Vaccine Market

8.4.3. Japan BCG Vaccine Market

8.4.4. Australia BCG Vaccine Market

8.4.5. South Korea BCG Vaccine Market

8.4.6. Rest of Asia Pacific BCG Vaccine Market

8.5. Latin America BCG Vaccine Market Snapshot

8.5.1. Brazil BCG Vaccine Market

8.5.2. Mexico BCG Vaccine Market

8.6. Rest of The World BCG Vaccine Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Merck & Co. Inc.

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Sanofi Pasteur

9.2.3. Japan BCG Laboratory

9.2.4. China National Biotech Group

9.2.5. Serum Institute of India Pvt. Ltd.

9.2.6. InterVax Ltd.

9.2.7. GreenSignal Bio Pharma Limited (GSBPL)

9.2.8. Statens Serum Institute

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global BCG Vaccine market, report scope

TABLE 2. Global BCG Vaccine market estimates & forecasts by Region 2017-2027 (USD Million)

TABLE 3. Global BCG Vaccine market estimates & forecasts by Type 2017-2027 (USD Million)

TABLE 4. Global BCG Vaccine market estimates & forecasts by Demographics 2017-2027 (USD Million)

TABLE 5. Global BCG Vaccine market estimates & forecasts by Application 2017-2027 (USD Million)

TABLE 6. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 7. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 8. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 9. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 10. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 11. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 12. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 13. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 14. Global BCG Vaccine market by segment, estimates & forecasts, 2017-2027 (USD Million)

TABLE 15. Global BCG Vaccine market by region, estimates & forecasts, 2017-2027 (USD Million)

TABLE 16. U.S. BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 17. U.S. BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 18. U.S. BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 19. Canada BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 20. Canada BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 21. Canada BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 22. UK BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 23. UK BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 24. UK BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 25. Germany BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 26. Germany BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 27. Germany BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 28. RoE BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 29. RoE BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 30. RoE BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 31. China BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 32. China BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 33. China BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 34. India BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 35. India BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 36. India BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 37. Japan BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 38. Japan BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 39. Japan BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 40. RoAPAC BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 41. RoAPAC BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 42. RoAPAC BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 43. Brazil BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 44. Brazil BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 45. Brazil BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 46. Mexico BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 47. Mexico BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 48. Mexico BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 49. RoLA BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 50. RoLA BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 51. RoLA BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 52. Row BCG Vaccine market estimates & forecasts, 2017-2027 (USD Million)

TABLE 53. Row BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 54. Row BCG Vaccine market estimates & forecasts by segment 2017-2027 (USD Million)

TABLE 55. List of secondary sources, used in the study of global BCG Vaccine market

TABLE 56. List of primary sources, used in the study of global BCG Vaccine market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Global BCG Vaccine Market Size study, by Type (Immune BCG and Therapy BCG) Demographics (Pediatrics (0-18 Years), Adults (19-35 Years)) Application (Hospitals, Clinics, Others) and Regional Forecasts 2020-2027

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara